JACOBIO PHARMACEUTICALS

jacobio-pharmaceuticals-logo

Jacobio Pharmaceuticals, founded in 2015 in Beijing China, is a clinical-stage biotech company dedicated to the development of global truly innovative drugs for the unmet needs in China and abroad. The vision and mission of Jacobio have become a global leader to provide revolutionary therapies for serious and life-threatening diseases such as cancer, autoimmune and infectious diseases. Jacobio is founded by seasoned executives from top global and local pharmaceuticals companies who have an asto... unding track record of success and backed by prestigious venture capital firms such as Lilly Asia Ventures and Qiming Capitals. Dr. Yinxiang Wang, the co-founder and chairman of Jacobio, also is one of the founders of Betta Pharmaceuticals, an A-share listed innovative pharmaceutical company, and the national "The Recruitment Program of Global Experts". The most senior management team has over 20 years of drug R&D experience and successfully brought several innovative drugs into the clinical and market stage. Within 3 years, Jacobio has quickly established a compelling drug R&D team of over 100 employees and one-stop capability covering target discovery, med-chemistry, pharmacology, CMC formulation, clinical, and registration. With those, the company has built up a rich pipeline of 8-10 assets with clear competitive advantages and excellent drug properties. JAB-3068, the most advanced program for Jacobio, has focused on a novel target potential for both immunotherapy and target therapy and enter Phase I clinical trial in US and IND approved at China and clinical trials would be initiate at China very soon.

#SimilarOrganizations #People #Financial #More

JACOBIO PHARMACEUTICALS

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2015-01-01

Status:
Active

Contact:
+86 010-56315466

Email Addresses:
[email protected]

Total Funding:
101.55 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Domain Not Resolving Mobile Non Scaleable Content Nginx IPv6 PHP PHP 7 FLoC Opt-Out


Similar Organizations

canbridge-pharmaceuticals-logo

CANbridge Pharmaceuticals

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

newbridge-pharmaceuticals-logo

NewBridge Pharmaceuticals

Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.


Current Advisors List

nisa-leung_image

Nisa Leung Board Member @ Jacobio Pharmaceuticals
Board_member
2017-03-14

Current Employees Featured

yinxiang-wang_image

Yinxiang Wang
Yinxiang Wang CEO and Chairman @ Jacobio Pharmaceuticals
CEO and Chairman

Founder


yinxiang-wang_image

Yinxiang Wang

Investors List

abbvie-biotech-ventures_image

AbbVie Biotech Ventures

AbbVie Biotech Ventures investment in Venture Round - Jacobio Pharmaceuticals

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series C - Jacobio Pharmaceuticals

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series C - Jacobio Pharmaceuticals

hillhouse-capital_image

Hillhouse Capital Group

Hillhouse Capital Group investment in Series C - Jacobio Pharmaceuticals

prudence-investment-management_image

Prudence Investment Management

Prudence Investment Management investment in Series C - Jacobio Pharmaceuticals

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Venture Round - Jacobio Pharmaceuticals

lilly-asia-ventures_image

Lilly Asia Ventures

Lilly Asia Ventures investment in Series B - Jacobio Pharmaceuticals

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series B - Jacobio Pharmaceuticals

Investments List

Date Company Article Money raised
2021-08-31 HebeCell Jacobio Pharmaceuticals investment in Series A - HebeCell 53 M USD

More informations about "Jacobio Pharmaceuticals" on Search Engine